查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
宏基因組測序市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按產品和服務、技術、按應用、地區和競爭細分
市場調查報告書
商品編碼
1326478

宏基因組測序市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按產品和服務、技術、按應用、地區和競爭細分

Metagenomics Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product and Service, By Technology, By Application, By Region, and By Competition
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計宏基因組測序市場在預測期內將出現令人印象深刻的成長。這可以歸因於人們對遺傳史引起的遺傳性疾病的認知不斷增強，以及對先進生物資訊學工具的需求不斷成長。此外，新藥和高通量篩選方法的不斷發展以及具有成本效益的技術發展預計將在預測期內創造利潤豐厚的成長。同樣，用於識別新型抗生素和酶的研發活動的增加是推動未來幾年市場成長的主要因素。例如，2022年8月，個性化醫療公司OpGen, Inc.宣佈在子公司Ares Genetics下推出下一代測序（NGS）服務。

個性化醫療需求不斷成長

個性化醫療是全球宏基因組測序市場成長的關鍵驅動力。個性化醫療旨在根據患者特定的基因組成和環境因素提供針對個體患者的針對性治療和治療。宏基因組測序為了解我們體內微生物的組成和功能提供了強大的工具，可用於開發慢性疾病的療法。宏基因組測序可用於識別患者腸道、皮膚或其他身體部位中存在的特定微生物，並確定這些微生物如何與患者的免疫系統和其他生理系統相互作用。這些資訊通常用於開發可以調節患者微生物組的療法，以治療癌症、糖尿病和炎症性腸病等疾病。此外，宏基因組測序可用於識別引起傳染病的特定病原體，並確定針對這些病原體的最有效治療方法。這有助於減少廣譜抗生素和其他可能導致抗生素耐藥性發展的治療方法的使用。

測序技術的進步

測序技術的進步對全球宏基因組測序市場的成長產生了重大影響。新一代測序和單分子測序技術極大地提高了宏基因組測序的通量、準確性和速度，使其更容易為包括研究人員和臨床醫生在內的更廣泛的用戶所使用。這些進步促進了新的生物資訊學工具和軟體的開發，可以更有效地分析宏基因組測序生成的大量數據。這些工具幫助研究人員和臨床醫生從宏基因組數據中提取更有意義的見解，並開發新的診斷和治療應用。此外，攜帶式測序技術的發展使得宏基因組測序能夠在現場進行，從而使研究偏遠或資源有限地區的微生物群落成為可能。這為環境監測、公共衛生和農業應用帶來了新的機遇。隨著測序技術的不斷進步，宏基因組測序的成本預計將繼續下降，從而使世界各地的研究人員和臨床醫生更容易獲得它。隨著該技術在一系列研究、臨床和商業應用中得到更廣泛的採用，預計這將推動全球宏基因組測序市場的成長。

對環境監測和管理的需求不斷增加

環境監測和管理是全球宏基因組測序市場成長的重要驅動力。宏基因組測序可用於研究各種環境中的微生物群落，包括土壤、水、空氣和建築環境。這些資訊可用於更好地了解這些社區的生態和功能，並製定更有效的環境管理和修復策略。

精準農業需求不斷成長

精準農業是全球宏基因組測序市場成長的關鍵驅動力。精準農業是一種利用數據驅動的方法來最佳化作物生產並減少對環境影響的農業技術。宏基因組測序可用於研究生活在土壤和植物上的微生物群落，並更好地了解這些群落之間關於植物健康和生長的相互作用。通過研究土壤和植物上的微生物群落，農民可以更好地了解作物的養分和水需求，以及它們對病蟲害的易感性。這些資訊可用於製定更有針對性的施肥、灌溉和害蟲管理策略，從而提高作物產量並減少對環境的影響。

宏基因組測序還可用於研究土壤微生物群落的多樣性及其在養分循環、碳固存和土壤團聚等土壤過程中的功能作用。這些資訊可用於製定永續農業的新戰略，促進土壤健康和恢復力，同時減少合成肥料和農藥的使用。隨著精準農業不斷受到關注，對宏基因組測序的需求預計將增加，從而推動更適合這些應用的新技術和分析工具的開發。此外，隨著農民、研究人員和農業企業採用宏基因組測序來最佳化作物生產並提高永續性，預計將推動全球宏基因組測序市場的成長。

基因組學研究資金的可用性不斷增加

政府對基因組研究的資助在全球宏基因組測序市場的成長中發揮了關鍵作用。基因組研究成本高昂，需要在設備、基礎設施和人員方面進行大量投資。政府資助可以幫助提供必要的資源來支持宏基因組測序領域的研究和開發。

政府資助支持了新的測序技術、生物資訊學工具和數據分析方法的開發，極大地提高了宏基因組測序的準確性和速度。這使得對更大、更複雜的樣本進行測序成為可能，從而對各種環境中微生物群落的多樣性和功能產生了新的見解。政府資助還支持宏基因組學研究轉化為臨床和商業應用。例如，政府資助支持開發基於宏基因組學的傳染病和癌症診斷測試，以及根據宏基因組學研究獲得的見解開發新藥和療法。

除了資助研究和開發之外，政府資助還可以幫助為在研究和臨床環境中採用宏基因組測序創造有利的政策環境。這可以包括促進基因組數據在醫療實踐和研究中使用的法規，以及促進不同研究小組之間共享基因組數據的舉措。

近期發展

  • Oxford Nanopore PromethION：Oxford Nanopore於2018年推出了PromethION測序平台，這是一種攜帶式、可擴展的系統，用於長DNA片段的即時測序。該平台可用於廣泛的應用，包括宏基因組測序。
  • QIAGEN Microbial Insights ARB：QIAGEN 於 2020 年推出了 Microbial Insights ARB，這是一款宏基因組分析軟體，使研究人員能夠研究微生物群落及其在各種環境中的功能。該軟體使用帶註釋的微生物基因組數據庫來提供宏基因組數據的準確分類學和功能分析。
  • 華大基因一站式微生物組測序服務：2022年，華大基因推出一站式微生物組測序服務，這是利用宏基因組測序分析微生物組樣本的綜合服務。該服務包括樣品製備、測序和數據分析，專為廣泛的應用而設計，包括醫學和環境研究。
  • PacBio Sequel IIe 系統：PacBio 於 2021 年推出了 Sequel IIe 系統，這是一個高通量、長讀長的測序平台，單次運行可生成高達 10 TB 的數據。該系統設計用於廣泛的應用，包括宏基因組測序。
  • Illumina DRAGEN Metagenomics Pipeline：2021年，Illumina推出了DRAGEN Metagenomics Pipeline，這是一種用於分析宏基因組測序數據的軟體解決方案。該管道使用先進的算法和機器學習技術來提供微生物群落的準確分類和功能分析。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球宏基因組測序市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務（試劑和消耗品、儀器、服務）
    • 按技術（鳥槍法宏基因組測序、16S rRNA 測序、全基因組測序和從頭組裝、元轉錄組學）
    • 按應用（藥物發現、生態和環境宏基因組學、臨床診斷、生物燃料、工業應用）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按產品和服務
    • 按技術
    • 按應用
    • 按地區

第 6 章：北美宏基因組測序市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務（試劑和消耗品、儀器、服務）
    • 按技術（鳥槍法宏基因組測序、16S rRNA 測序、全基因組測序和從頭組裝、元轉錄組學）
    • 按應用（藥物發現、生態和環境宏基因組學、臨床診斷、生物燃料、工業應用）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲宏基因組測序市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務（試劑和消耗品、儀器、服務）
    • 按技術（鳥槍法宏基因組測序、16S rRNA 測序、全基因組測序和從頭組裝、元轉錄組學）
    • 按應用（藥物發現、生態和環境宏基因組學、臨床診斷、生物燃料、工業應用）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區宏基因組測序市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務（試劑和消耗品、儀器、服務）
    • 按技術（鳥槍法宏基因組測序、16S rRNA 測序、全基因組測序和從頭組裝、元轉錄組學）
    • 按應用（藥物發現、生態和環境宏基因組學、臨床診斷、生物燃料、工業應用）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章：南美宏基因組測序市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務（試劑和消耗品、儀器、服務）
    • 按技術（鳥槍法宏基因組測序、16S rRNA 測序、全基因組測序和從頭組裝、元轉錄組學）
    • 按應用（藥物發現、生態和環境宏基因組學、臨床診斷、生物燃料、工業應用）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲宏基因組測序市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按產品和服務（試劑和消耗品、儀器、服務）
    • 按技術（鳥槍法宏基因組測序、16S rRNA 測序、全基因組測序和從頭組裝、元轉錄組學）
    • 按應用（藥物發現、生態和環境宏基因組學、臨床診斷、生物燃料、工業應用）
    • 按國家/地區
  • MEA：國家分析
    • 南非宏基因組測序
    • 沙烏地阿拉伯宏基因組測序
    • 阿拉伯聯合大公國宏基因組測序

第 11 章：市場動態

  • 司機
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球宏基因組測序市場：SWOT 分析

第 14 章：波特的五力分析

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • BGI Genomics Co Ltd.
    • Eurofins Scientific Se.
    • Illumina Inc.
    • Macrogen Inc.
    • Oxford Nanopore Technologies Ltd.
    • Pacific Biosciences of California Inc.
    • Perkinelmer Inc.
    • Qiagen NV
    • Swift Biosciences Inc.
    • Thermo Fisher Scientific Inc.

第 16 章：戰略建議

簡介目錄
Product Code: 15130

Metagenomics Sequencing Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing awareness about genetic disorders due to genetic history, along with the growing demand for advanced bioinformatics tools. Also, a growing development of novel drugs and high throughput screening methods along with cost-effective technologies developments are expected to create lucrative growth during the forecast period. Similarly, the rise in research and development activities for identifying newer antibiotics and enzymes is a major factor fueling the growth of the market over the upcoming years. For instance, in August 2022, OpGen, Inc., a personalized medicine company, announced to launch of next-generation sequencing (NGS) services under the subsidiary Ares Genetics.

Growing demand for personalized medicine

Personalized medicine is a key driver for the growth of the Global Metagenomics Sequencing Market. Personalized medicine aims to provide targeted therapies and treatments that are tailored to the individual patient based on their specific genetic makeup and environmental factors. Metagenomics sequencing provides a powerful tool for understanding the composition and function of microbes that are present in our body and can be used to develop therapies for chronic diseases. Metagenomics sequencing can be used to identify the specific microbes present in a patient's gut, skin, or other body sites and determine how these microbes interact with the patient's immune system and other physiological systems. This information is generally used to develop therapies that can modulate the patient's microbiome for treating the conditions such as cancer, diabetes, and inflammatory bowel disease. In addition, metagenomics sequencing can be used to identify the specific pathogens that are causing an infectious disease and to determine the most effective treatments for those pathogens. This can help to reduce the use of broad-spectrum antibiotics and other treatments that can lead to the development of antibiotic resistance.

Advancements in sequencing technologies

Advancements in sequencing technologies have had a significant impact on the growth of the Global Metagenomics Sequencing Market. Next-generation sequencing and single-molecule sequencing technologies have greatly enhanced the throughput, accuracy, and speed of metagenomics sequencing, making it more accessible to a wider range of users, including researchers and clinicians. These advancements have led to the development of new bioinformatics tools and software that can more effectively analyze the vast amounts of data generated by metagenomics sequencing. These tools help researchers and clinicians to extract more meaningful insights from metagenomics data and develop new diagnostic and therapeutic applications. In addition, the development of portable sequencing technologies is enabling metagenomics sequencing to be performed in field settings, making it possible to study microbial communities in remote or resource-limited areas. This is opening new opportunities for environmental monitoring, public health, and agriculture applications. As sequencing technologies continue to advance, the cost of metagenomics sequencing is expected to continue to decline, making it more accessible to researchers and clinicians around the world. This is expected to drive the growth of the global metagenomics sequencing market as the technology becomes more widely adopted in a range of research, clinical, and commercial applications.

Increasing need for environmental monitoring and management

Environmental monitoring and management are important drivers of the growth of the Global Metagenomics Sequencing Market. Metagenomics sequencing can be used to study microbial communities in a wide range of environments, including soil, water, air, and the built environment. This information can be used to better understand the ecology and function of these communities and to develop more effective strategies for environmental management and remediation.

Particularly, metagenomics sequencing can be used to identify and monitor microbial indicators of environmental health, such as pathogenic bacteria, fungi, and viruses. This can be important for identifying and managing outbreaks of infectious diseases in human and animal populations and for monitoring the health of ecosystems and natural resources. In addition, metagenomics sequencing can be used to study the impact of environmental stressors, such as pollution and climate change, on microbial communities and their functions. The growing demand for environmental monitoring and management is driving the development of new metagenomics sequencing technologies and analytical tools that are better suited to these applications.

Rising demand for precision agriculture

Precision agriculture is a key driver for the growth of the global metagenomics sequencing market. Precision agriculture is a farming technique that uses data-driven approaches to optimize crop production and reduce environmental impact. Metagenomics sequencing can be used to study the microbial communities that live in the soil and on plants and to better understand the interactions between these communities about plant health and growth. By studying the microbial communities in the soil and on plants, farmers can gain a better understanding of the nutrient and water requirements of crops, as well as their susceptibility to pests and diseases. This information can be used to develop more targeted fertilization, irrigation, and pest management strategies, leading to increased crop yields and reduced environmental impact.

Metagenomics sequencing can also be used to study the diversity of soil microbial communities and their functional roles in soil processes such as nutrient cycling, carbon sequestration, and soil aggregation. This information can be used to develop new strategies for sustainable agriculture that promote soil health and resilience while also reducing the use of synthetic fertilizers and pesticides. As precision agriculture continues to gain traction, the demand for metagenomics sequencing is expected to increase, driving the development of new technologies and analytical tools that are better suited to these applications. Further, expected to drive the growth of the Global Metagenomics Sequencing Market as farmers, researchers, and agribusinesses adopt metagenomics sequencing to optimize crop production and improve sustainability.

Growing availability of funding for genomics research

Government funding for genomic research has played a critical role in the growth of the Global Metagenomics Sequencing Market. Genomic research is expensive and requires significant investment in equipment, infrastructure, and personnel. Government funding can help to provide the necessary resources to support research and development in the field of metagenomics sequencing.

Government funding has supported the development of new sequencing technologies, bioinformatics tools, and data analysis methods, which have greatly enhanced the accuracy and speed of metagenomics sequencing. This has made it possible to sequence larger and more complex samples, which has led to new insights into the diversity and function of microbial communities in a range of environments. Government funding has also supported the translation of metagenomics research into clinical and commercial applications. For example, government funding has supported the development of metagenomics-based diagnostic tests for infectious diseases and cancer, as well as the development of new drugs and therapies based on insights gained from metagenomics research.

In addition to funding research and development, government funding can help to create a favorable policy environment for the adoption of metagenomics sequencing in research and clinical settings. This can include regulations that promote the use of genomic data in medical practice and research, as well as initiatives that promote the sharing of genomic data across different research groups.

Recent Development

  • Oxford Nanopore PromethION: Oxford Nanopore launched the PromethION sequencing platform in 2018, which is a portable and scalable system for real-time sequencing of long DNA fragments. The platform can be used for a wide range of applications, including metagenomics sequencing.
  • QIAGEN Microbial Insights ARB: QIAGEN launched the Microbial Insights ARB in 2020, which is a metagenomics analysis software that enables researchers to study microbial communities and their functions in various environments. The software uses a database of annotated microbial genomes to provide accurate taxonomic and functional analysis of metagenomic data.
  • BGI One-Stop Microbiome Sequencing Service: In 2022, BGI launched its One-Stop Microbiome Sequencing Service, which is a comprehensive service for analyzing microbiome samples using metagenomics sequencing. The service includes sample preparation, sequencing, and data analysis and is designed for a wide range of applications, including medical and environmental research.
  • PacBio Sequel IIe System: PacBio launched the Sequel IIe System in 2021, which is a high-throughput, long-read sequencing platform that can generate up to 10 terabases of data in a single run. The system is designed for a wide range of applications, including metagenomics sequencing.
  • Illumina DRAGEN Metagenomics Pipeline: In 2021, Illumina launched its DRAGEN Metagenomics Pipeline, which is a software solution for analyzing metagenomics sequencing data. The pipeline uses advanced algorithms and machine learning techniques to provide accurate taxonomic and functional analysis of microbial communities.

Market Segmentation

Global Metagenomics Sequencing Market can be segmented by product and service, technology, application, and by region. Based on the product and service, the market can be segmented into reagents & consumables, instruments, and services. Based on technology, the market can be segmented into shotgun metagenomic sequencing, 16S rRNA sequencing, whole genome sequencing & de novo assembly, and metatranscriptomics. Based on application, the market can be differentiated into drug discovery, ecological & environmental metagenomics, clinical diagnostics, biofuel, and industrial applications.

Market Players

BGI Genomics Co Ltd., Eurofins Scientific Se., Illumina Inc., Macrogen Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Perkinelmer Inc., Qiagen N.V., Swift Biosciences Inc., Thermo Fisher Scientific Inc. are some of the leading players operating in the Global Metagenomics Sequencing Market.

Report Scope:

In this report, Global Metagenomics Sequencing market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Metagenomics Sequencing Market, By Product and Service:

  • Reagents & consumables
  • Instruments
  • Services

Metagenomics Sequencing Market, By Technology:

  • Shotgun metagenomic sequencing
  • 16S rRNA sequencing
  • Whole genome sequencing & de novo assembly
  • Meta transcriptomics

Metagenomics Sequencing Market, By Application:

  • Drug discovery
  • Ecological & environmental metagenomics
  • Clinical diagnostics
  • Biofuel
  • Industrial applications

Metagenomics Sequencing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Metagenomics Sequencing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Metagenomics Sequencing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
    • 5.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
    • 5.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Product & services
    • 5.3.2 By Technology
    • 5.3.3 By Application
    • 5.3.4 By Region

6. North America Metagenomics Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
    • 6.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
    • 6.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Metagenomics Sequencing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product & Services
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Metagenomics Sequencing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product & Services
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Metagenomics Sequencing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product & Services
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application

7. Europe Metagenomics Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
    • 7.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
    • 7.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Metagenomics Sequencing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product & Services
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Metagenomics Sequencing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product & Services
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Metagenomics Sequencing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product & Services
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Metagenomics Sequencing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product & Services
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Metagenomics Sequencing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product & Services
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application

8. Asia-Pacific Metagenomics Sequencing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
    • 8.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
    • 8.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Metagenomics Sequencing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product & Services
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
    • 8.3.2. India Metagenomics Sequencing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product & Services
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Metagenomics Sequencing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product & Services
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Metagenomics Sequencing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product & Services
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Metagenomics Sequencing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product & Services
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application

9. South America Metagenomics Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
    • 9.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
    • 9.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Metagenomics Sequencing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product & Services
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Metagenomics Sequencing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product & Services
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Metagenomics Sequencing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product & Services
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application

10. Middle East and Africa Metagenomics Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service (Reagents & consumables, Instruments, Services)
    • 10.2.2. By Technology (Shotgun metagenomic sequencing, 16S rRNA sequencing, Whole genome sequencing & de novo assembly, Meta transcriptomics)
    • 10.2.3. By Application (Drug discovery, Ecological & environmental metagenomics, Clinical diagnostics, Biofuel, Industrial applications)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Metagenomics Sequencing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product & Services
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Metagenomics Sequencing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product & Services
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Metagenomics Sequencing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product & Services
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Metagenomics Sequencing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 BGI Genomics Co Ltd.
    • 15.6.2 Eurofins Scientific Se.
    • 15.6.3 Illumina Inc.
    • 15.6.4 Macrogen Inc.
    • 15.6.5 Oxford Nanopore Technologies Ltd.
    • 15.6.6 Pacific Biosciences of California Inc.
    • 15.6.7 Perkinelmer Inc.
    • 15.6.8 Qiagen N.V.
    • 15.6.9 Swift Biosciences Inc.
    • 15.6.10 Thermo Fisher Scientific Inc.

16. Strategic Recommendations